Protein Binding: Do We Ever Learn?
Open Access
- 1 July 2011
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (7), 3067-3074
- https://doi.org/10.1128/aac.01433-10
Abstract
Although the influence of protein binding (PB) on antibacterial activity has been reported for many antibiotics and over many years, there is currently no standardization for pharmacodynamic models that account for the impact of protein binding of antimicrobial agents in vitro . This might explain the somewhat contradictory results obtained from different studies. Simple in vitro models which compare the MIC obtained in protein-free standard medium versus a protein-rich medium are prone to methodological pitfalls and may lead to flawed conclusions. Within in vitro test systems, a range of test conditions, including source of protein, concentration of the tested antibiotic, temperature, pH, electrolytes, and supplements may influence the impact of protein binding. As new antibiotics with a high degree of protein binding are in clinical development, attention and action directed toward the optimization and standardization of testing the impact of protein binding on the activity of antibiotics in vitro become even more urgent. In addition, the quantitative relationship between the effects of protein binding in vitro and in vivo needs to be established, since the physiological conditions differ. General recommendations for testing the impact of protein binding in vitro are suggested.Keywords
This publication has 116 references indexed in Scilit:
- Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo MicrodialysisAntimicrobial Agents and Chemotherapy, 2010
- Significance of Protein Binding in Pharmacokinetics and PharmacodynamicsJournal of Pharmaceutical Sciences, 2010
- Pharmacodynamics of Tigecycline against Phenotypically Diverse Staphylococcus aureus Isolates in a Murine Thigh ModelAntimicrobial Agents and Chemotherapy, 2009
- Protein Binding of Antimicrobials: Methods for Quantification and for Investigation of its Impact on Bacterial KillingThe AAPS Journal, 2009
- Effect of Protein Binding on the Pharmacological Activity of Highly Bound AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- Pharmacodynamic Effects of Telavancin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the Presence of Human Albumin or Serum and in an In Vitro Kinetic ModelAntimicrobial Agents and Chemotherapy, 2007
- Binding interactions of pefloxacin mesylate with bovine lactoferrin and human serum albuminJournal of Zhejiang University-SCIENCE B, 2006
- Measurement and Analysis of Unbound Drug ConcentrationsClinical Pharmacokinetics, 1996
- EXPERIMENTAL PNEUMOCOCCUS INFECTION IN MICE: COMPARATIVE IN VITRO AND IN VIVO EFFECT OF CEFUROXIME, CEFOTAXIME AND CEFTRIAXONEActa Pathologica Microbiologica Scandinavica Series B: Microbiology, 1987
- Binding of physostigmine to rat and human plasma and crystalline serum albuminsLife Sciences, 1985